Page 5 - Peer Perform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peer Perform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peer Perform Today - Breaking & Trending Today

What's Going On With Crispr Therapeutics Stock? - CRISPR Therapeutics (NASDAQ:CRSP)

Published: February 15, 2024

Crispr Therapeutics shares are trading higher Thursday after Wolfe Research analyst Andy Chen initiated coverage on Crispr Therapeutics with a Peer Perform rating. Crispr Therapeutics' shares have risen nearly 37% over the past month following the FDA approval of Casgevy (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 gene-edited cell therapy, for transfusion-dependent beta-thalassemia (TDT) in patients 12 years and older on Jan. 16.

Source: benzinga.com

Reliance Steel & Aluminum Posts Upbeat Earnings, Joins JFrog, AppLovin, Shake Shack And Other Big Stocks Moving Higher On Thursday

Published: February 15, 2024

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday. Shares of Reliance Steel & Aluminum Co. ...

Source: businessinsider.com

Why Is Alnylam Pharmaceuticals Stock Trading Lower On Thursday? - Alnylam Pharmaceuticals (NASDAQ:ALNY)

Published: February 15, 2024

Alnylam Pharmaceuticals' updates on HELIOS-B Phase 3 study and FDA clearance for ALN-APP Phase 1 study. Fiscal year 2024 guidance of $1.4 billion–$1.5 billion in combined net product revenues.

Source: benzinga.com